New hope for rett syndrome? early drug trial begins
NCT ID NCT07150013
Summary
This early-stage study is testing a drug called vorinostat to see if it is safe and can help control symptoms of Rett syndrome. Up to 15 girls and young women with Rett syndrome will take the drug for several months, with each person's results compared to their own baseline. The main goal is to check for safety and see if the drug shows any signs of improving symptoms like movement, behavior, and seizures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETT SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Grupo de Investigación Clínica PECET (GIC-PECET)
Medellín, Colombia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.